2007年
| • | Acquired three HA manufacturers, i.e., Songjiang Factory, Shanghai Jianhua and Qisheng Biological. |
| • | Market in ophthalmology, orthopedics and general surgery |
2012年
| • | First generation dermal filler “Martrifill海薇“ was approved by NMPA and launched in |
2015年
| • | Listed on HKSE Main Board |
| • | Merged 6 intraocular lens-related companies and completed the whole industry chain presence of IOL from raw materials, R&D, production to sales |
2019年
| • | Listed on SSE Star Market |
| • | The first domestic hydrophilic aspheric IOL approved |
| • | New generation ophthalmic material “Optimum Infinite” was launched |
2020年
| • | Acquired Hangzhou Aijinglun and obtained refractive lens PRL (依镜） |
| • | Third generation dermal filler Hyalumatrix (海魅) approved |
2021年
| • | Expanded into the field of photoelectric equipment by acquiring JUVA |
| • | Invested in a botulinum toxin company, Eirion |
| • | Obtaining the exclusive right to distribute two OK lens brands in China. |
| • | Acquired Hebei Xinshikang to expand the soft contact lens market |
Company Overview